CAMBRIDGE, Mass.–(BUSINESS WIRE)–ConcertAI, a frontrunner in oncology generative and agentic AI SaaS and multi-modal information (MMD) options for healthcare and life sciences, right this moment introduced the combination of the American Society of Scientific Oncology® (ASCO®) Pointers via the CARAai platform for its Precision Suite and CancerLinQ® SmartLinQ options™. Now, the ability of the Precision Suite’s low-latency and high-recency information can be utilized by biopharma researchers to evaluate Guideline-concordant c
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/concertai-provides-intelligent-automation-of-asco-guidelines-into-its-generative-and-agentic-ai-precision-suite-and-cancerlinq-smartlinq-solutions/
